Moving beyond transition outcomes: Meta-analysis of remission rates in individuals at high clinical risk for psychosis

Psychiatry Research

Volumn 209, Issue 3, 2013, Pages 266-272

  Simon, Andor E ^a,b,c   Borgwardt, Stefan ^a   Riecher Rössler, Anita ^a   Velthorst, Eva ^d   de Haan, Lieuwe ^d   Fusar Poli, Paolo ^e  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Specialized Early Psychosis Outpatient Service for Adolescents and Young Adults   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ARMS; At risk; Prodromal; Psychosis; Schizophrenia; UHR

Indexed keywords

ADOLESCENT; ADULT; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOMETRY; PSYCHOSIS; PUBLICATION; QUALITATIVE ANALYSIS; REMISSION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ARMS; AT RISK; PRODROMAL; PSYCHOSIS; SCHIZOPHRENIA; UHR;

DATABASES, FACTUAL; HUMANS; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; REMISSION, SPONTANEOUS; RISK FACTORS;

EID: 84885468677     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.03.004     Document Type: Review

References (66)

1. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. American Journal of Psychiatry 2011, 168:800-805.
2. Bechdolf A., Muller H., Stutzer H., Wagner M., Maier W., Lautenschlager M., Heinz A., de Millas W., Janssen B., Gaebel W., Michel T.M., Schneider F., Lambert M., Naber D., Brüne M., Krüger-Özgürdal S., Wobrock T., Riedel M., Klosterkötter J., PREVENT study group Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophrenia Bulletin 2011, 37(2):S111-S121.
3. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946, 2:47-53.
4. Bevan Jones R., Thapar A., Lewis G., Zammit S. The association between early autistic traits and psychotic experiences in adolescence. Schizophrenia Research 2012, 135:164-169.
5. Borenstein M., Higgins J., Rothstein H. Comprehensive Meta-Analysis Version 2 2005, Biostat, Englewood, NJ, USA.
6. Carpenter W.T., van Os J. Should attenuated psychosis syndrome be a DSM-V diagnosis?. American Journal of Psychiatry 2011, 168:460-463.
7. Cornblatt B., Lencz T., Smith C.W., Correll C.U., Auther A., Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin 2003, 29:633-651.
8. Cunill R., Castells X., Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. Journal of Clinical Psychiatry 2009, 70:70-82.
9. David A.S. Should the diagnostic boundaries of schizophrenia be expanded?. Cognitive Neuropsychiatry 2011, 16:97-100.
10. Eaton W.W., Romanoski A., Anthony J.C., Nestadt G. Screening for psychosis in the general population with a self-report interview. Journal of Nervous and Mental Disease 1991, 179:689-693.
11. Egger M., Davey Smith G, Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
12. Escher S., Romme M., Buiks A., Delespaul P., Van Os J. Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study. British Journal of Psychiatry 2002, 43:s10-s18.
13. Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F. Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L.J., Valmaggia, L., Cannon, T., Velthorst, E., De Haan, L., Cornblatt, B., Bonoldi, I., Birchwood, M., McGlashan, T., Carpenter, W., McGorry, P., Klosterkötter, J., McGuire, P., Yung,A. Thesychosis high risk state: a comprehensive state of the art review. Archives of General Psychiatry, 2013. JAMA Psychiatry 70, 107-120.
14. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: a meta-analysis of evidence. Archives of General Psychiatry 2012, 69:220-229.
15. Fusar-Poli, P., Bechdolf, A., Taylor, M., Bonoldi, I., Carpenter, W., Yung, A., McGuire, P., At risk for schizophrenic or affective psychosis? A meta-analysis of ICD/DSM diagnostic outcomes in individuals at high clinical risk. Schizophrenia Bulletin, in press-b.
16. Fusar-Poli P., Borgwardt S. Predictive power of attenuated psychosis syndrome: is it really low? The case of mild cognitive impairment. Schizophrenia Research 2012, 135:192-193.
17. Fusar-Poli P., Yung A. Should attenuated psychosis syndrome be included in the DSM5? The debate. The Lancet 2012, 379:591-592.
18. Gross G., Huber G., Klosterkötter J., Linz M. Bonn Scale for the Assessment of Basic Symptoms-BSABS. Berlin-Heidelberg-New York 1987, Springer.
19. Hanssen M., Bak M., Bijl R., Vollebergh W., van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 2005, 44:181-191.
20. Haroun N., Dunn L., Haroun A., Cadenhead K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin 2006, 32:166-178.
21. Hürlimann F., Kupferschmid S., Simon A.E. Cannabis-induced depersonalization disorder in adolescence. Neuropsychobiology 2012, 65:141-146.
22. Joa I., Johannessen J.O., Auestad B., Friis S., McGlashan T., Melle I., Opjordsmoen S., Simonsen E, Vaglum P., Larsen T.K. The key to reducing duration of untreated first psychosis: information campaigns. Schizophrenia Bulletin 2008, 34:466-472.
23. Johns L.C., van Os J. The continuity of psychotic experiences in the general population. Clinical Psychology Review 2001, 21:1125-1141.
24. Kendler K.S., Gallagher T.J., Abelson J.M., Kessler R.C. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Archives of General Psychiatry 1996, 53:1022-1031.
25. Lemos-Giráldez S., Vallina-Fernández O., Fernández-Iglesias P., Vallejo-Seco G., Fonseca-Pedrero E., Paíno-Piñeiro M., Sierra-Baigrie S., García-Pelayo P., Pedrejón-Molino C., Alonso-Bada S., Gutiérrez-Pérez A., Ortega-Ferrández J.A. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophrenia Research 2009, 115:121-129.
26. Lipsey M., Wilson D. Practical Meta-analysis 2000, Sage Publications, Thousand Oaks, CA.
27. McGlashan T.H., Johannessen J.O. Early detection and intervention with schizophrenia: rationale. Schizophrenia Bulletin 1996, 22:201-222.
28. McGlashan, T.H., 2001. Structured Interview for Prodromal Syndromes (Version 3.0, unpublished manuscript). PRIME Research Clinic, Yale School of Medicine, New Haven, Connecticut.
29. McGorry P.D., Edwards J., Mihalopoulos C., Harrigan S.M., Jackson H.J. EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bulletin 1996, 22:305-326.
30. McGorry P.D. The specialist youth mental health model: strengthening the weakest link in the public mental health system. Medical Journal of Australia 2007, 187(7):S53-S56.
31. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 2002, 159:863-865.
32. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal 2009, 339:b2535.
33. Morrison A.P., Stewart S.L., French P., Bentall R.P., Birchwood M., Byrne R., Davies L.M., Fowler D., Gumley A.I., Jones P.B., Lewis S.W., Murray G.K., Patterson P., Dunn G. Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Intervention in Psychiatry 2011, 5:24-32.
34. Moskowitz A., Heim G. Eugen Bleuler's Dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration. Schizophrenia Bulletin 2011, 37:471-479.
35. Nielssen O., Large M. Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis. Schizophrenia Bulletin 2010, 36:702-712.
36. Orwin R. A fail-safe N for effect size in meta-analysis. Journal of Educational Statistics 1983, 8:157-159.
37. Paulson J.F., Bazemore S.D. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. Journal of the American Medical Association 2010, 303:1961-1969.
38. Petersen R.C., Roberts R.O., Knopman D.S., Boeve B.F., Geda Y.E., Ivnik R.J., Smith G.E., Jack C.R. Mild cognitive impairment: ten years later. Archives of Neurology 2009, 66:1447-1455.
39. Riecher-Rössler A., Aston J., Ventura J., Merlo M., Borgwardt S., Gschwandtner U., Stieglitz R.D. The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity. Fortschritte Neurologie Psychiatrie 2008, 76:207-216.
40. Riecher-Rössler A., Pflueger M.O., Aston J., Borgwardt S.J., Brewer W.J., Gschwandtner U., Stieglitz R.D. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biological Psychiatry 2009, 66:1023-1030.
41. Rietdijk J., Dragt S., Klaassen R., Ising H., Nieman D., Wunderink L., Delespaul P., Cuijpers P., Linszen D., van der Gaag M. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial. Trials 2010, 11:30.
42. Rössler W., Riecher-Rössler A., Angst J., Murray R., Gamma A., Eich D., van Os J., Gross V.A. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophrenia Research 2007, 92:1-14.
43. Rössler W., Hengartner M.P., Ajdacic-Gross V., Haker H., Gamma A., Angst J Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders. Schizophrenia Research 2011, 131:18-23.
44. Schlosser D.A., Jacobson S., Chen Q., Sugar C.A., Niendam T.A., Li G., Bearden C.E., Cannon T.D. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophrenia Bulletin 2012, 38:1225-1233.
45. Schultze-Lutter F., Addington J., Ruhrmann S., Klosterkötter J. Schizophrenia Proneness Instrument, Adult version (SPI-A) 2007, Giovanni Fiorito Editore, Rome.
46. Schultze-Lutter, F., Klosterkötter, J., Michel, C., Winkler, K., Ruhrmann, S., 2012. Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis. Early Intervention in Psychiatry, published online Jan 19.x. [Epub ahead of print]. http://dx.doi.org/10.1111/j.1751-7893.2011.00324.
47. Siever L.J., Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. American Journal of Psychiatry 2004, 161:398-413.
48. Simon A.E., Umbricht D. Is elevated striatal dopamine function a prodromal sign of schizophrenia?. Archives of General Psychiatry 2009, 66:916-917.
49. Simon A.E., Cattapan-Ludewig K., Gruber K., Ouertani J., Zimmer A., Roth B., Isler E., Umbricht D. Subclinical hallucinations in adolescent outpatients: an outcome study. Schizophrenia Research 2009, 108:265-271.
50. Simon A.E., Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophrenia Research 2010, 116:168-172.
51. Simon A.E., Velthorst E., Nieman D.H., Linszen D., Umbricht D., de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophrenia Research 2011, 132:8-17.
52. Smieskova R., Fusar-Poli P., Aston J., Simon A., Bendfeldt K., Lenz C., Stieglitz R.D., McGuire P., Riecher-Rössler A., Borgwardt S.J. Insular volume abnormalities associated with different transition probabilities to psychosis. Psychological Medicine 2012, 30:1-13.
53. Smieskova R., Allen P., Simon A., Aston J., Bendfeldt K., Drewe J., Gruber K., Gschwandtner U., Klarhoefer M., Lenz C., Scheffler K., Stieglitz R.D., Radue E.W., McGuire P., Riecher-Rössler A., Borgwardt S.J. Different duration of at-risk mental state associated with neurofunctional abnormalities-a multimodal imaging study. Human Brain Mapping 2012, 33:2281-2294.
54. van Os J., Hanssen M., Bijl R.V., Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophrenia Research 2000, 45:11-20.
55. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 2009, 39:179-195.
56. van Os J., Linscott R.J. Introduction: the extended psychosis phenotype-relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophrenia Bulletin 2012, 38:227-230.
57. Varghese D., Scott J., Welham J., Bor W., Najman J., O'Callaghan M., Williams G., McGrath J. Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophrenia Bulletin 2009, 37:389-393.
58. Velthorst E., Nieman D.H., Klaassen R.M., Becker H.E., Dingemans P.M., Linszen D.H., De Haan L. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatrica Scandinavica 2011, 123:36-42.
59. Verdoux H., van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research 2002, 54:59-65.
60. Werbeloff N., Drukker M., Dohrenwend B.P., Levav I., Yoffe R., van Os J., Davidson M., Weiser M. Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Archives of General Psychiatry 2012, 69:467-475.
61. Wigman J.T., van Nierop M., Vollebergh W.A., Lieb R., Beesdo-Baum K, Wittchen H.U., van Os J. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity-implications for diagnosis and ultra-high risk research. Schizophrenia Bulletin 2012, 38:247-257.
62. Woods S.W., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 2009, 35:894-908.
63. Yung A.R., Phillips L.J., McGorry P.D., Ward J., Donovan K., Thompson K. Comprehensive Assessment of At Risk Mental States (CAARMS) PACE Clinic 2002, Department of Psychiatry, University of Melbourne, Melbourne.
64. Yung A.R., Yuen H.P., Berger G., Francey S., Hung T.C., Nelson B., Phillips L., McGorry P. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophrenia Bulletin 2007, 33:673-681.
65. Yung A., Nelson B., Yuen H.P., Spiliotacopoulos D., Lin A., Simmons M., Bruxner A., Broussard C., Thompson A., McGorry P. Long term outcome in an ultra high risk ("prodromal") group. Schizophrenia Bulletin 2011, 37(1):22-23.
66. Ziermans T., Schothorst P., Sprong M., Van Engeland E. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophrenia Research 2011, 126:58-64.